Global End-to-End Biologics CDMO

Global end-to-end CDMO specializing in protein-based biologics and gene therapy, offering services for AAV, lentiviral, and other viral vector programs. With over 20 years of experience and 205+ successful client programs, we provide integrated solutions — from cell line development to manufacturing of cGMP Drug Substance and Drug Product, including viral clearance studies.
Our cGMP facilities in Lithuania, and Massachusetts (MA), support rapid, scalable manufacturing from early development to commercial phases. Known for scientific excellence, regulatory compliance, and a collaborative approach, Northway Biotech helps clients accelerate gene therapy development with speed, precision, and flexibility.